Alvelestat for use in the treatment of graft rejection, bronchiolitis obliterans syndrome and graft versus host disease
US-2022354833-A1 · Nov 10, 2022 · US
Nat Cancer Institute holds 2 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 2 |
| Recent patents | 0 |
| First publication | Jun 11, 2020 |
| Latest publication | Nov 10, 2022 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
Representative or frequently cited publications from precomputed assignee stats.
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 1 |
| Chemistry & Metallurgy | 1 |
| Physics | 1 |